beta

AFMD

Affimed NV

Afmd

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Affimed NV engages in discovering and developing of targeted cancer immunotherapies. Its pipelines include Innate Cell Engagers and T Cell Engagers. The company was founded in 2000 and is headquartered in Heidelberg, Germany.

Market Cap: 174 Million

Primary Exchange: NASDAQ

Website: http://www.affimed.com

Shares Outstanding: 76.2 Million

Float: 61.8 Million

Dividend: (%)

Beta: 1.53639766764798

Sector: Health Technology

Industry: Biotechnology

Ethical Flags

Animal testing

Longest drawdown: 1121 trading days

From: 2015-07-17 To: 2019-12-10

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud